System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma

Table 2

Basic data of patients between different risk groups.

Characteristics	TCGA-LIHC cohort		P value
	High risk	Low risk
Gender (%)			0.063
Female	51(28.0%)	68(37.2%)
Male	131(72.0%)	115(62.8%)
Age (%)			0.783
<65y	109(59.9%)	107(58.5%)
≥65y	73(40.1%)	76(41.5%)
TNM stage (%)			0.408
I+II	121(66.5%)	133(72.7%)
III+IV	47(25.8%)	40(21.9%)
unknown	14(7.7%)	10(5.5%)
Grade (%)			<0.001
G1+G2	96(52.7%)	134(73.2%)
G3+G4	83(45.6%)	47(25.7%)
unknown	3(1.6%)	2(1.1%)
Survival status (%)			<0.001
Living	101(55.5%)	134(73.2%)
Death	81(44.5%)	49(26.8%)